Improvement of nimesulide dissolution from solid dispersions containing croscarmellose sodium and Aerosil® 200

Acta Pharmaceutica

Volumn 52, Issue 4, 2002, Pages 227-241

  Gohel, Mukesh C ^a   Patel, Laxman D ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Aerosil 200; Croscarmellose sodium; Factorial design; In vitro drug dissolution; Nimesulide; Solid dispersions

Indexed keywords

AEROSIL; CROSCARMELLOSE SODIUM; DODECYL SULFATE SODIUM; DRUG VEHICLE; MACROGOL 400; NIMESULIDE; POLYSORBATE 20; POVIDONE DERIVATIVE; POVIDONE K30; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DRUG ANALYSIS; DRUG EFFICACY; DRUG RELEASE; DRUG SOLUBILITY; WETTABILITY;

EID: 0036990759     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. K. P. R. Chowdary, K. V. R. Murthy and C. D. S. Prasad, Solid dispersions of nimodipine: Physico-chemical and dissolution rate studies, Indian Drugs 32 (1995) 537-542.
2. J. Kerc, S. Srcic and B. Kofler, Alternative solvent-free preparation methods for felodipine surface solid dispersions, Drug Dev. Ind. Pharm. 24 (1998) 359-363.
3. J. M. Newton and F. N. Razzo, The influence of the additive on the presentation of a drug in hard gelatin capsules, J. Pharm. Pharmacol. 29 (1997) 294-297.
4. M. H. Rubinstein and E. J. Price, In-vivo evaluation of the effect of five disintegrants on the biovailability of furosemide from tablets, J. Pharm. Pharmacol. 29 (1997) 5P.
5. A. K. Singla and D. K. Mediratta, Influence of sodium lauryl sulphate on indomethacin release pattern from zinc-indomethacin complex and indomethacin capsules, Drug Dev. Ind. Pharm. 14 (1998) 1883-1888.
6. G. L. Amidon, Jinno and J. R. Crison, Dissolution of ionizable water-soluble drugs: The combined effect of pH and surfactant, J. Pharm. Sci. 89 (2000) 268-274.
7. S. Mutalik, Venkatesh and N. Udupa, Fast analgesic activity from recrystallized nimesulide and its solid dispersion, Indian J. Physiol. Pharmacol. 46 (2000) 115-116.
8. J. S. Botzolakis and L. L. Augsburger, The role of disintegrants in hard gelatin capsules, J. Pharm. Pharmacol. 36 (1984) 77-84.
9. J. S. Botzolakis and L. L. Augsburger, Disintegrating agents in hard gelatin capsules. Part I: Mechanism of action, Drug Dev. Ind. Pharm. 14 (1998) 29-41.
10. J. S. Botzolakis and L. L. Augsburger, Disintegrating agents in hard gelatine capsules. Part II: Swelling efficiency, Drug Dev. Ind. Pharm. 14 (1988) 1235-1248.
11. J. Ringard and A. M. Guyot-Hermann, Calculation of disintegrant critical concentration in order to optimize tablets disintegration, Drug Dev. Ind. Pharm. 14 (1998) 2321-2339.
12. S. L. Law and C. H. Chiang, Improving dissolution rates griseofulvin by dispositon on disintegrants, Drug Dev. Ind. Pharm. 16 (1990) 137-147.
13. K. P. R. Chowdary and N. Rama Rao, Evaluation pregelatinised starch as tablet excipients for improving dissolution rate and efficiency of nimodipine, Int. J. Pharm. Excip. 1 (1999) 20-24.
14. N. H. Shah, J. H. Lazarus, P. R. Sheth and C. I. Jaworski, Carboxymethyl cellulose: Effect of degree of polymerization and substitution of tablet disintegration and dissolution, J. Pharm. Sci. 70 (1981) 611-613.
15. E. A. Gorman, C. T. Rhodes and E. M. Rudnic, Evaluation of croscarmellose as a tablet disintegrant in direct compression systems, Drug Dev. Ind. Pharm. 8 (1982) 397-410.
16. U. V. Bankar, A. V. Dewoolkar and R. Soni, Sodium starch glycolate: A contemporary review, Int. J. Pharm. Excip. 1 (1999) 4-9.
17. A. S. Kornblum and S. B. Stoopak, New tablet disintegrating agent: Cross-linked polyvinylpyrrolidone, J. Pharm. Sci. 62 (1973) 43-49.
18. G. S. Bankar and H. R. Anderson, Tablets, in The Theory and Practice of Industrial Pharmacy, Fourth Indian Edition (Eds. L. Lachman, H. A. Liberman, and J. L. Kanig), Verghese Publishing House, Bombay 1991, pp. 328.
19. D. Harpaz, Colloidal Silicon Dioxide, in Handbook of Pharmaceutical Excipients, Second Edition (Eds: A. Wade and J. W. Paul), American Pharmaceutical Association/The Pharmaceutical Press, Washington DC/London 1994, pp. 424.
20. G. Piel, B. Pirotte, I. Delneuville, P. Neven, G. Llabres, J. Delarge and L. Delattre, Study of the influence of both cyclodextrin and L-lysine on the aqeous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrine complexes, J. Pharm. Sci. 86 (1997) 475-480.
21. M. C. Gohel and L. D. Patel, Improvement of Nimesulide dissolution by co-grinding method using surfactants, Pharm. Pharmacol. Commun. 6 (2000) 433-440.
22. M. C. Gohel and L. D. Patel, Processing of Nimesulide-PEG 400-PG-PVP Solid Dispersions: Preparation, Characterization and in-vitro Dissolution, Drug Dev. Ind. Pharm., in press.
23. A. McKenna and D. F. McCafferty, Effect of particle size on the compaction mechanism tensile strength of tablets, J. Pharm. Pharmacol. 34 (1982) 347-351.
24. United States Pharmacopoea 23/National Formulary 18, United States Pharmacopeial Convention, Rockville 1995, pp. 1791.
25. P. Tandon and R. Mishra, Development of multiple w / o / w emulsions showing prolonged anti-inflammatory activity of nimesulide, Acta Pharm. Turcia 41 (1999) 15-18.
26. C. Lefebvre, A. M. Barthelemy and G. Hermann, An attempt at bringing to light a »Phase inversion« in a binary mixture of two dimensional rounded particles, Drug Dev. Ind. Pharm. 14 (1988) 2443-2465.
27. X. M. Zeng, G. P. Martin, C. Marriott and J. Pritchard, The influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols, J. Pharm. Pharmacol. 52 (2000) 633-643.
28. B. C. Hancock and M. Parks, What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17 (2000) 397-404.
29. K. A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol. 27 (1975) 48-49.
30. J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Technol. 20 (1996) 64-74.
31. S. Y. Lin, Y. H. Kao and J. C. Yang, Grinding effect on some pharmaceutical properties of drugs by adding β-cyclodextrine, Drug Dev. Ind. Pharm. 14 (1988) 99-118.
32. M. Wulff and M. Alden, Solid-state of drug-cyclodextrine inclusion complexes in PEG 6000 prepared by a new method, Eur. J. Pharm. Sci. 8 (1999) 269-281.